Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

India Globalization Capital IGC

Alternate Symbol(s):  IGCIW

"India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. The company has focused on four products that it is preparing for medical trials, Natrinol, Caesafin, Serosapse, and Hyalolex."

Latest Bullboard Posts

India Globalization Capital Inc. = Fraud, your money is lost
Maximum - November 20, 2018

Going to $10.00

Buy buy buy
Thebiggbee - November 9, 2018

What happened

Friom Marketwatch
SAGE1 - October 30, 2018

IGC is delisted off the exchange, IGC hype is over

I feel soo sorry for those who bought @ $15, the last day of the hypbe, tickher is off the exchange now, all trading blocked as of...
NewYorker85 - October 30, 2018


this is not an investment....its a trade based on mostly hyped up if your in now anything can happen to the downside...
chuck16 - October 9, 2018

2nd time in

woke up and this was up 40%   bought 4000 shares....sold in a hour at $6.70.....2nd time in this...first time sold at 36% upside.......
chuck16 - October 8, 2018


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.